CCM
UTHR icon

Cinctive Capital Management’s United Therapeutics UTHR Stock Holding History

Cinctive Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,515
Closed -$3.86M – 557
2026
Q1 		$3.86M Buy
6,515
+5,278
+427% +$2.63M 0.25% 136
2025
Q4 		$603K Sell
1,237
-6,270
-84% -$2.92M 0.03% 320
2025
Q3 		$3.15M Buy
+7,507
New +$2.52M 0.15% 204
2024
Q3 		– Sell
-5,762
Closed -$1.84M – 527
2024
Q2 		$1.84M Buy
5,762
+3,039
+112% +$804K 0.09% 260
2024
Q1 		$626K Sell
2,723
-2,559
-48% -$577K 0.03% 329
2023
Q4 		$1.16M Buy
+5,282
New +$1.22M 0.08% 239
2021
Q4 		– Sell
-27,362
Closed -$5.05M – 661
2021
Q3 		$5.05M Sell
27,362
-27,321
-50% -$5.38M 0.25% 132
2021
Q2 		$9.81M Sell
54,683
-7,598
-12% -$1.45M 0.46% 47
2021
Q1 		$10.4M Buy
62,281
+2,133
+4% +$356K 0.64% 27
2020
Q4 		$9.13M Buy
60,148
+4,395
+8% +$577K 0.74% 23
2020
Q3 		$5.63M Buy
55,753
+14,247
+34% +$1.56M 0.49% 61
2020
Q2 		$5.02M Sell
41,506
-3,970
-9% -$447K 0.58% 44
2020
Q1 		$4.31M Sell
45,476
-18,724
-29% -$1.78M 0.96% 25
2019
Q4 		$5.66M Buy
+64,200
New +$5.65M 0.59% 77

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cinctive Capital Management's UTHR Position: Q2 2026 in Review

Cinctive Capital Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 6,515 shares — an estimated $3.86M sold.

Cinctive Capital Management first reported a position in UTHR in Q4 2019 and held it in 14 quarters. The position peaked at $10.4M in Q1 2021. 879 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cinctive Capital Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 6,515 United Therapeutics shares in Q2 2026, an estimated $3.86M.
  • Cinctive Capital Management first reported a position in United Therapeutics in Q4 2019 and held it in 14 quarters.
  • Cinctive Capital Management's United Therapeutics position peaked at $10.4M in Q1 2021.
  • 879 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.